BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30268665)

  • 1. Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models.
    Chiorazzi A; Wozniak KM; Rais R; Wu Y; Gadiano AJ; Farah MH; Liu Y; Canta A; Alberti P; Rodriguez-Menendez V; Meregalli C; Fumagalli G; Monza L; Pozzi E; Vornov JJ; Polydefkis M; Pietra C; Slusher BS; Cavaletti G
    Eur J Pharmacol; 2018 Dec; 840():89-103. PubMed ID: 30268665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats.
    Meregalli C; Marjanovic I; Scali C; Monza L; Spinoni N; Galliani C; Brivio R; Chiorazzi A; Ballarini E; Rodriguez-Menendez V; Carozzi VA; Alberti P; Fumagalli G; Pozzi E; Canta A; Quartu M; Briani C; Oggioni N; Marmiroli P; Cavaletti G
    J Neuroinflammation; 2018 Aug; 15(1):232. PubMed ID: 30131066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies.
    Carozzi VA; Canta A; Oggioni N; Sala B; Chiorazzi A; Meregalli C; Bossi M; Marmiroli P; Cavaletti G
    Exp Neurol; 2010 Dec; 226(2):301-9. PubMed ID: 20832406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparison of the Central versus Peripheral Gastrointestinal Prokinetic Activity of Two Novel Ghrelin Mimetics.
    Mohammadi EN; Pietra C; Giuliano C; Fugang L; Greenwood-Van Meerveld B
    J Pharmacol Exp Ther; 2019 Jan; 368(1):116-124. PubMed ID: 30377215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analgesic efficacy of pregabalin administered according to either a prevention protocol or an intervention protocol in rats with cisplatin-induced peripheral neuropathy.
    Han FY; Kuo A; Nicholson JR; Corradinni L; Smith MT
    Clin Exp Pharmacol Physiol; 2018 Oct; 45(10):1067-1075. PubMed ID: 29781509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ghrelin receptor agonist HM01 mimics the neuronal effects of ghrelin in the arcuate nucleus and attenuates anorexia-cachexia syndrome in tumor-bearing rats.
    Borner T; Loi L; Pietra C; Giuliano C; Lutz TA; Riediger T
    Am J Physiol Regul Integr Comp Physiol; 2016 Jul; 311(1):R89-96. PubMed ID: 27147616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New ghrelin agonist, HM01 alleviates constipation and L-dopa-delayed gastric emptying in 6-hydroxydopamine rat model of Parkinson's disease.
    Karasawa H; Pietra C; Giuliano C; Garcia-Rubio S; Xu X; Yakabi S; Taché Y; Wang L
    Neurogastroenterol Motil; 2014 Dec; 26(12):1771-82. PubMed ID: 25327342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats.
    Meregalli C; Canta A; Carozzi VA; Chiorazzi A; Oggioni N; Gilardini A; Ceresa C; Avezza F; Crippa L; Marmiroli P; Cavaletti G
    Eur J Pain; 2010 Apr; 14(4):343-50. PubMed ID: 19695912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple Beneficial Effects of Ghrelin Agonist, HM01 on Homeostasis Alterations in 6-Hydroxydopamine Model of Parkinson's Disease in Male Rats.
    Minalyan A; Gabrielyan L; Pietra C; Taché Y; Wang L
    Front Integr Neurosci; 2019; 13():13. PubMed ID: 31031602
    [No Abstract]   [Full Text] [Related]  

  • 10. Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity.
    Bianchi R; Brines M; Lauria G; Savino C; Gilardini A; Nicolini G; Rodriguez-Menendez V; Oggioni N; Canta A; Penza P; Lombardi R; Minoia C; Ronchi A; Cerami A; Ghezzi P; Cavaletti G
    Clin Cancer Res; 2006 Apr; 12(8):2607-12. PubMed ID: 16638873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Z-505 hydrochloride ameliorates chemotherapy-induced anorexia in rodents via activation of the ghrelin receptor, GHSR1a.
    Shiomi Y; Ohira Y; Yoshimura M; Ozaki T; Takei M; Tanaka T
    Eur J Pharmacol; 2018 Jan; 818():148-157. PubMed ID: 29066414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-emetic Action of the Brain-Penetrating New Ghrelin Agonist, HM01, Alone and in Combination With the 5-HT
    Rudd JA; Chan SW; Ngan MP; Tu L; Lu Z; Giuliano C; Lovati E; Pietra C
    Front Pharmacol; 2018; 9():869. PubMed ID: 30127745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ghrelin alleviates cancer chemotherapy-associated dyspepsia in rodents.
    Liu YL; Malik NM; Sanger GJ; Andrews PL
    Cancer Chemother Pharmacol; 2006 Sep; 58(3):326-33. PubMed ID: 16435157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The orally active glutamate carboxypeptidase II inhibitor E2072 exhibits sustained nerve exposure and attenuates peripheral neuropathy.
    Wozniak KM; Wu Y; Vornov JJ; Lapidus R; Rais R; Rojas C; Tsukamoto T; Slusher BS
    J Pharmacol Exp Ther; 2012 Dec; 343(3):746-54. PubMed ID: 22988061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotoxicity to DRG neurons varies between rodent strains treated with cisplatin and bortezomib.
    Podratz JL; Kulkarni A; Pleticha J; Kanwar R; Beutler AS; Staff NP; Windebank AJ
    J Neurol Sci; 2016 Mar; 362():131-5. PubMed ID: 26944133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin prevents cisplatin-induced mechanical hyperalgesia and cachexia.
    Garcia JM; Cata JP; Dougherty PM; Smith RG
    Endocrinology; 2008 Feb; 149(2):455-60. PubMed ID: 17962345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™).
    Canta A; Chiorazzi A; Carozzi V; Meregalli C; Oggioni N; Sala B; Crippa L; Avezza F; Forestieri D; Rotella G; Zucchetti M; Cavaletti G
    Cancer Chemother Pharmacol; 2011 Oct; 68(4):1001-8. PubMed ID: 21327681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site and mechanism of the colokinetic action of the ghrelin receptor agonist, HM01.
    Naitou K; Mamerto TP; Pustovit RV; Callaghan B; Rivera LR; Chan AJ; Ringuet MT; Pietra C; Furness JB
    Neurogastroenterol Motil; 2015 Dec; 27(12):1764-71. PubMed ID: 26416336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assessment of chemotherapy-induced peripheral neurotoxicity using a point-of-care nerve conduction device.
    Matsuoka A; Mitsuma A; Maeda O; Kajiyama H; Kiyoi H; Kodera Y; Nagino M; Goto H; Ando Y
    Cancer Sci; 2016 Oct; 107(10):1453-1457. PubMed ID: 27412083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: new useful ready-to-use animal models.
    Carozzi VA; Chiorazzi A; Canta A; Meregalli C; Oggioni N; Cavaletti G; Marmiroli P
    Exp Neurol; 2015 Feb; 264():92-102. PubMed ID: 25450467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.